The increasing CD4+CD25+FOXP3+ Treg percentage was also closely in accordance with the TNM staging and lymph node metastasis status, which is consistent with previous studies [17,18]. The gene discussed is CD4; the disease is metastatic malignant neoplasm in the lymph nodes.